Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results

被引：0
|
作者：
Yadav, Madhav [1 ]
Ballal, Sanjana [1 ]
Bal, Chandrasekhar [1 ]
Tripathi, Madhavi [1 ]
机构：
[1] All India Inst Med Sci, Nucl Med, New Delhi, India
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
589
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617
    Mike M. Sathekge
    Frank Bruchertseifer
    Ismaheel O. Lawal
    Mariza Vorster
    Otto Knoesen
    Thabo Lengana
    Tebatso G. Boshomane
    Kgomotso K. Mokoala
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1756 - 1757
  • [22] Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617
    Sathekge, Mike M.
    Bruchertseifer, Frank
    Lawal, Ismaheel O.
    Vorster, Mariza
    Knoesen, Otto
    Lengana, Thabo
    Boshomane, Tebatso G.
    Mokoala, Kgomotso K.
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (08) : 1756 - 1757
  • [23] 225Ac-PSMA-617 Targeted Therapy in MCRPC
    Pappas, Virginia
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (10) : 26N - 26N
  • [24] 225Ac-PSMA-617 treatment and follow up in advanced stage metastatic castration resistant prostate cancer: First clinical experience from Azerbaijan
    Novruzov, F.
    Aliyev, J.
    Guliyev, F.
    Abbasov, B.
    Mehmetbeyli, L.
    Mehdi, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S650 - S650
  • [25] Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617:Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
    Kratochwil, Clemens
    Bruchertseifer, Frank
    Rathke, Hendrik
    Hohenfellner, Markus
    Giesel, Frederik L.
    Haberkorn, Uwe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 795 - 802
  • [26] Treatment of Multiple Bone Metastases of Castration-Resistant Prostate Cancer With 225Ac-PSMA-617
    Yang, Hongyu
    Zhang, Yu
    Su, Dan
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1078 - 1081
  • [27] Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy
    Sathekge, Mike
    Bruchertseifer, Frank
    Vorster, Mariza
    Lawal, Ismaheel O.
    Knoesen, Otto
    Mahapane, Johncy
    Davis, Cindy
    Reyneke, Florette
    Maes, Alex
    Kratochwil, Clemens
    Lengana, Thabo
    Giesel, Frederik L.
    Van de Wiele, Christophe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 62 - 69
  • [28] Murine models of prostate cancer to study resistance mechanisms to targeted alpha therapy using 225Ac-PSMA-617
    Meyer, Catherine
    Stuparu, Andreea
    Wei, Liu
    Czernin, Johannes
    Dahlbom, Magnus
    Slavik, Roger
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [29] Optimizing the treatment regimen for targeted alpha therapy of mCRPC with 225Ac-PSMA-617
    Bruchertseifer, Frank
    Kratochwil, Clemens
    Rathke, Hendrik
    Haberkorn, Uwe
    Morgenstern, Alfred
    Giesel, Frederik
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [30] Initial experience with 225Ac-PSMA-617 in patients with advanced-stage prostate cancer
    Sathekge, Machaba
    Knoesen, Otto
    Bruchertseifer, Frank
    Reyneke, Florette
    Kratochwil, Clemens
    Lengana, Thabo
    Giesel, Frederik
    Lawal, Ismaheel
    Boshomane, Gill
    Vorster, Mariza
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
12345